Biological determinants of altered pharmacokinetics in the elderly
- PMID: 7044905
- DOI: 10.1159/000212568
Biological determinants of altered pharmacokinetics in the elderly
Abstract
The biological determinants of drug disposition have been clearly identified and methods are available to quantify what effects altering them will have on drug kinetics. The factors include blood flow and intrinsic clearance of the organ of elimination, drug binding in blood and tissues, and, in the case of drugs eliminated by the liver, the oral route of administration. The effects of these various factors on drug elimination depend on the efficiency of the elimination process. At one end of the spectrum, some drug elimination is very efficient as it is largely flow-dependent, while at the other elimination depends largely on intrinsic clearance. The oral route of elimination may be important for drugs which undergo efficient hepatic extraction, when a large "first-pass" effect results. In addition, that fraction of the drug escaping first-pass elimination is largely dependent on intrinsic clearance and not flow. Finally, plasma drug binding may affect both elimination and drug distribution. The way in which these factors can be affected by the aging process will be discussed and illustrated with examples showing how changes in organ blood flow, intrinsic clearance and plasma drug binding can produce pharmacokinetic changes seen in the elderly.
Similar articles
-
Altered hepatic blood flow and drug disposition.Clin Pharmacokinet. 1976;1(2):135-55. doi: 10.2165/00003088-197601020-00005. Clin Pharmacokinet. 1976. PMID: 13954 Review.
-
Clinical significance of pharmacokinetic models of hepatic elimination.Clin Pharmacokinet. 1990 Jan;18(1):61-76. doi: 10.2165/00003088-199018010-00004. Clin Pharmacokinet. 1990. PMID: 2178850 Review.
-
Commentary: a physiological approach to hepatic drug clearance.Clin Pharmacol Ther. 1975 Oct;18(4):377-90. doi: 10.1002/cpt1975184377. Clin Pharmacol Ther. 1975. PMID: 1164821
-
Comparative pharmacokinetic changes and drug therapy in an older population.J Am Geriatr Soc. 1982 Nov;30(11 Suppl):S11-9. doi: 10.1111/j.1532-5415.1982.tb01351.x. J Am Geriatr Soc. 1982. PMID: 6752251 Review.
-
A new model-independent physiological approach to study hepatic drug clearance and its applications.Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):577-90. Int J Clin Pharmacol Ther Toxicol. 1984. PMID: 6389376 Review.
Cited by
-
Pharmacokinetics of ceftazidime in elderly volunteers.Antimicrob Agents Chemother. 1985 Nov;28(5):713-5. doi: 10.1128/AAC.28.5.713. Antimicrob Agents Chemother. 1985. PMID: 3911883 Free PMC article.
-
Effect of age on the disposition of sodium fluoride.Eur J Clin Pharmacol. 1992;43(3):295-7. doi: 10.1007/BF02333026. Eur J Clin Pharmacol. 1992. PMID: 1425895
-
Effect of age and renal function on cefonicid pharmacokinetics.Antimicrob Agents Chemother. 1989 Feb;33(2):142-6. doi: 10.1128/AAC.33.2.142. Antimicrob Agents Chemother. 1989. PMID: 2719458 Free PMC article.
-
Effects of age and gender on pharmacokinetics of cefepime.Antimicrob Agents Chemother. 1992 Jun;36(6):1181-5. doi: 10.1128/AAC.36.6.1181. Antimicrob Agents Chemother. 1992. PMID: 1416818 Free PMC article.
-
Aromatase inhibitors in malignant diseases of aging.Drugs Aging. 1992 Nov-Dec;2(6):530-45. doi: 10.2165/00002512-199202060-00008. Drugs Aging. 1992. PMID: 1493356 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical